tirzepatide and hashimoto's Cancer Risk in Individuals with and without Diabetes: A Systematic Review and Meta-Analysis Investigating FDA Reports of Tirzepatide-Thyroid

The defining feature of this molecule is the unusual gamma-peptide linkage between glutamate and cysteine, which protects the compound from being rapidly degraded by standard intracellular peptidases

This pentadecapeptide demonstrates remarkable stability compared to most peptides, maintaining activity in gastric acid environments that rapidly degrade other protein fragments

Kleme JJ, Fan YV, Jiang P

The clinical usefulness of CCK as an anti-obesity, appetite reducing agent was found, however, to be transient due to the development of tolerance to CCK and its analogs (43)

(European Communities Council Directive of 24 November 1986 (86/609/EEC))